Beans are a key food at the dietary level, boasting high nutritional value and constituting the most directly consumed legume ...

Biohacking has moved from niche experiments to a global movement reshaping how we think about human potential. With ...

UMD researchers have discovered key mechanisms in gene regulation that could improve the design of RNA-based medicines.

Bristol Myers Squibb's FDA nod for Breyanzi (liso-cel) in relapsed/refractory CLL/SLL boosts its CAR T-cell portfolio, ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is a pioneer in gene-editing technology, using its patented gene sequencing platform to ...

Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR ...

Variant Bio recently announced a multimillion-dollar deal with a pharmaceutical company, and some of that money will go to ...

Beans are a key food at the dietary level, boasting high nutritional value and constituting the most directly consumed legume ...

The platform enables direct, unbiased genome-wide identification and quantification of the exact position of double strand DNA breaks in edited cells.